多靶点分子治疗阿尔茨海默病的研究进展(5)
 |
| 第6页 |
 |
| 第1页 |
参见附件。
[18] Grassmann S，Apelt J，Sippl W，et al.Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities[J].Bioorg Med Chem，2003，11(10)：2163-2174.
[19] Incerti M，Flammini L，Saccani F，et al.Dual-acting drugs： an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity[J].Chem Med Chem，2010，5(7)：1143-1149.
[20] Chen Y，Sun J，Fang L，et al.Tacrine-ferulic acid-nitric oxide (NO)donor trihybrids as potent， multifunctional acetyl- and butyrylcholinesterase inhibitors[J].J Med Chem，2012，55(9)：4309-4321.
[21] Wang Y，Guan XL，Wu PF，et al.Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases[J].J Med Chem，2012，55(7)：3588-3592.
[22] Chen X，Zenger K，Lupp A，et al.Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo[J].J Med Chem，2012，55(11)：5231-5242.
[23] Beauchard A，Ferandin Y，Frere S，et al.Synthesis of novel 5-substituted indirubins as protein kinases inhibitors[J].Bioorg Med Chem，2006，14(18)：6434-6443.
[24] Chioua M，Samadi A，Soriano E，et al.Synthesis and biological evaluation of 3，6-diamino-1H-pyrazolo[3，4-b]pyridine derivatives as protein kinase inhibitors[J].Bioorg Med Chem Lett，2009，19(16)：4566-4569.
(收稿日期：2014-04-19)
您现在查看是摘要介绍页，详见PDF附件。